These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
299 related items for PubMed ID: 22727797
41. [Therapy of cardiac arrhythmias using cardioversion]. de Carvalho Filho ET, Ping W, Carneiro L. Arq Bras Cardiol; 1970 Aug; 23(4):269-78. PubMed ID: 4919806 [No Abstract] [Full Text] [Related]
42. [Clinical case of the month. Atrial flutter with rapid ventricular response (1:1 atrioventricular conduction) caused by flecaïnide]. Robinet S, Melon R, Piérard L. Rev Med Liege; 2007 Dec; 62(12):701-3. PubMed ID: 18286943 [Abstract] [Full Text] [Related]
43. Efficacy and Safety of Vernakalant for Cardioversion of Recent-onset Atrial Fibrillation in the Asia-Pacific Region: A Phase 3 Randomized Controlled Trial. Beatch GN, Bhirangi K, Juul-Moller S, Rustige J. J Cardiovasc Pharmacol; 2017 Feb; 69(2):86-92. PubMed ID: 27828791 [Abstract] [Full Text] [Related]
44. The vernakalant story: how did it come to approval in Europe and what is the delay in the U.S.A? Camm AJ. Curr Cardiol Rev; 2014 Nov; 10(4):309-14. PubMed ID: 24821654 [Abstract] [Full Text] [Related]
45. [Arrhythmia following immediately after cardioversion of auricular fibrillation and auricular flutter]. Wink K, Hager W. Z Kreislaufforsch; 1971 Apr; 60(4):318-29. PubMed ID: 5578072 [No Abstract] [Full Text] [Related]
46. Real-world Data on the Efficacy of Vernakalant for Pharmacological Cardioversion in Patients With Recent-onset Atrial Fibrillation. Cosin-Sales J, Loscos A, Peiró A, Sorando MR, Buendía F, Ruescas L. Rev Esp Cardiol (Engl Ed); 2016 Jun; 69(6):619-20. PubMed ID: 27131972 [No Abstract] [Full Text] [Related]
48. Tachycardia due to atrial flutter with rapid 1:1 conduction following treatment of atrial fibrillation with flecainide. Taylor R, Gandhi MM, Lloyd G. BMJ; 2010 Mar 10; 340():b4684. PubMed ID: 20219811 [Abstract] [Full Text] [Related]
50. Positive atrial inotropic effect of dofetilide after cardioversion of atrial fibrillation or flutter. DeCara JM, Pollak A, Dubrey S, Falk RH. Am J Cardiol; 2000 Sep 15; 86(6):685-8, A8. PubMed ID: 10980226 [Abstract] [Full Text] [Related]
51. [Vernakalant: a novel antiarrhythmic drug for the rapid conversion of atrial fibrillation to sinus rhythm]. Hirt MN, Eschenhagen T. Dtsch Med Wochenschr; 2010 May 15; 135(19):971-6. PubMed ID: 20446233 [Abstract] [Full Text] [Related]
52. Unstable wide complex tachycardia during propafenone therapy. Tsai CF, Sia SK, Lin MC, Wu DJ, Ueng KC. Resuscitation; 2010 Aug 15; 81(8):1046-7. PubMed ID: 20488610 [No Abstract] [Full Text] [Related]
53. [Treatment of atrial fibrillation in intensive care units and emergency departments]. Arrigo M, Bettex D, Rudiger A. Med Klin Intensivmed Notfmed; 2015 Nov 15; 110(8):614-20. PubMed ID: 25876744 [Abstract] [Full Text] [Related]
54. 2014 AATS guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures. Executive summary. Frendl G, Sodickson AC, Chung MK, Waldo AL, Gersh BJ, Tisdale JE, Calkins H, Aranki S, Kaneko T, Cassivi S, Smith SC, Darbar D, Wee JO, Waddell TK, Amar D, Adler D, American Association of Thoracic Surgery. J Thorac Cardiovasc Surg; 2014 Sep 15; 148(3):772-91. PubMed ID: 25129583 [No Abstract] [Full Text] [Related]